News

Your contact person

Manager PR & Communications Jan Phillip Denkers

The Hamburg iGEM team at this year's student competition for synthetic biology in Paris. (Image: Laurenz Stammel)
The Hamburg iGEM team at this year's student competition for synthetic biology in Paris. From left to right, front row: Evangelos Masis, Lucy Jansen, Kristina Boneß. From left to right, back row: Joel Martins Ribeiro, Ole Hunke, Mariia Vvedenskaia, Marius Beßler, Laurenz Stammel, Milo Krömer. (Image: Laurenz Stammel)

iGEM Hamburg Team Awarded Gold Medal

With their project “DeathCapTrap,” the iGEM Hamburg team developed an antidote to one of the most dangerous fungal toxins in the world. They were awarded ...

Read more …
The NIHR’s Nordic Virtual Office will open a direct line to NIHR and its Industry team and its vast research ecosystem. (Image: HALRIC)
The NIHR’s Nordic Virtual Office will open a direct line to NIHR and its Industry team and its vast research ecosystem. (Image: HALRIC)

Launch of the NIHR Nordic Virtual Office

What if the next gateway to UK health innovation wasn’t a place, but a virtual office, one that connects the Nordics and Northern Germany directly ...

Read more …
Biotech and pharmaceutical companies will now have exclusive access to NexMR’s photo-induced NMR through CrystalsFirst, benefiting from the synergy of two advanced platforms working in tandem.v
Biotech and pharmaceutical companies will now have exclusive access to NexMR’s photo-induced NMR through CrystalsFirst, benefiting from the synergy of two advanced platforms working in tandem. (Image: unsplash/D koi)

NexMR joins forces with CrystalsFirst

CrystalsFirst GmbH, a leader in high-performance structural biology services, and NexMR AG, a pioneer in ultrafast NMR screening, today announced an exclusive partnership to accelerate ...

Read more …
Indivumed and Aptila join forces in a new proteomics collaboration. (Photo: Indivumed)
Indivumed and Aptila join forces in a new proteomics collaboration. (Photo: Indivumed)

Indivumed announces collaboration utilizing Aptila’s proteomics expertise

Indivumed is pleased to announce a close working relationship with Aptila as of August 2025. Aptila’s software suite, DIA-NN, is a leading solution for data-independent ...

Read more …
10,000 m² of contract logistics space for medical technology and reagents (Photo: Sysmex/Kuehne+Nagel)
10,000 m² of contract logistics space for medical technology and reagents (Photo: Sysmex/Kuehne+Nagel)

Kuehne+Nagel: New distribution centre for Sysmex

Kuehne+Nagel has opened a new distribution centre for Sysmex Europe SE and Sysmex Deutschland GmbH, dedicated to diagnostic instruments and reagents. As part of its ...

Read more …
Mindpeak opens Boston office (Image: Mindpeak)
Mindpeak opens Boston office (Image: Mindpeak)

Mindpeak Opens Boston Office

Mindpeak, a global leader in AI-powered pathology solutions, today announced the launch of Mindpeak Inc., its dedicated US entity. Strategically positioned near key pharmaceutical, biotech, ...

Read more …
Patrick Frey, one of the contributors to the study team, is delighted with the award and the corresponding recognition of the study results. (Photo: Mindpeak)
Patrick Frey, one of the contributors to the study team, is delighted with the award and the corresponding recognition of the study results. (Photo: Mindpeak)

Mindpeak wins Best Poster Award

We’re thrilled to share that our poster titled “Large-scale validation of a robust artificial intelligence algorithm for detection of invasive breast cancer on H&E images” ...

Read more …
The NIHR is the UK’s largest public funder of health and care research. (Image: NIHR)
The NIHR is the UK’s largest public funder of health and care research. (Image: NIHR)

A new strategic collaboration

A new strategic collaboration between life science clusters from Northern Europe and the UK’s National Institute for Health and Care Research (NIHR) is set to ...

Read more …
More than fifty researchers, industrial and community partners will gather from several European countries to give start to this ambitious cross-sectoral, public-private research partnership. (Image: Viromarkers)
More than fifty researchers, industrial and community partners will gather from several European countries to give start to this ambitious cross-sectoral, public-private research partnership. (Image: Viromarkers)

altona industrial leader in Viromarkers research project

altona Diagnostics is part of the Viromarkers project, a European research initiative dedicated to advancing virus-related biomarkers for the management of chronic infections, which officially ...

Read more …
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)

Pacira BioSciences Acquires GQ Bio

HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...

Read more …
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)

CrystalsFirst Scales Operations...

CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...

Read more …
medac has received FDA approval for treosulfan (Copyright Adobe Stock - Nicolas Hermbach)

Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT

medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

Read more …